There is no evidence that screening the entire adult population over the age of 45 for
diabetes will decrease morbidity or mortality. What is certain is that screening will do a great …

Background No clinical trials have assessed the effects or cost-effectiveness of sequential
screening strategies to detect new cases of type 2 diabetes. We used a mathematical model …

Screening for Type 2 Diabetes Mellitus - Abstract - Europe PMC Sign in | Create an account
https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …

Over the past decade it has been obvious that the prevalence of type 2 diabetes is
increasing rapidly. Unless appropriate action is taken, it is predicted that there will be at least …

Screening guidelines proposed by the Expert Committee on the Diagnosis and
Classification of Diabetes Mellitus have been endorsed by several medical societies …

Screening for diabetes implies testing for diabetes in individuals without symptoms who are
unaware of their condition. Screening for diabetes will also detect individuals at increased …

Background: Type 2 diabetes mellitus is associated with a heavy burden of suffering.
Screening for diabetes is controversial. Purpose: To examine the evidence that screening …

The recommendation from the Canadian Task Force on Preventive Health Care that
screening for type 2 diabetes is not recommended, except in very high-risk patient groups, is …

Context.—Type 2 diabetes mellitus is a common and serious disease in the United States,
but one third of those affected are unaware they have it. Objective.—To estimate the cost …

Abstract Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by
destruction of insulin-producing β cells in the pancreas. The incidence of T1D is increasing …